Trends of skin diseases in organ-transplant recipients transplanted between 1966 and 2006: a cohort study with follow-up between 1994 and 2006

Br J Dermatol. 2010 Feb 1;162(2):390-6. doi: 10.1111/j.1365-2133.2009.09529.x. Epub 2009 Oct 3.

Abstract

Background: Skin diseases are frequently observed in organ-transplant recipients (OTRs).

Objectives: To count the registered skin diseases in all 2136 OTRs who had been transplanted in a single centre between 1966 and 2006 and to calculate their relative contribution in relation to the number of years after transplantation.

Methods: All registered skin diseases which were entered into a computerized system between 1994 and 2006 at the Leiden University Medical Centre were counted and their relative contributions were calculated.

Results: Between 1994 and 2006, 2408 skin diseases were registered in 801 of 1768 OTRs who were at risk during this specific time period. The most commonly recorded diagnoses were skin infections (24.0%) followed by benign skin tumours (23.3%) and malignant skin lesions (18.2%). The relative contributions of infectious and inflammatory disorders decreased with time after transplantation, whereas the contribution of squamous cell carcinomas strongly increased with time.

Conclusions: This study gives a systematic overview of the high burden of skin diseases in OTRs. The relative distributions of skin diseases importantly changed with time after transplantation, with squamous cell carcinoma contributing most to the increasing burden of skin diseases with increasing time after transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cohort Studies
  • Follow-Up Studies
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Risk Factors
  • Skin Diseases / epidemiology*
  • Skin Diseases / etiology
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / etiology
  • Time Factors
  • Transplants / adverse effects*
  • Transplants / statistics & numerical data

Substances

  • Immunosuppressive Agents